Gene-editing technique CRISPR identifies dangerous breast cancer mutations

Mutations in BRCA genes are linked to the early onset of breast and ovarian cancers. But the effect of most mutations is unclear. Now new research can distinguish harmless from dangerous mutations.

Fighting Cancer With Quantum Computing

CRISPR in cancer biology and therapy

BRCA mutations can be deadly or harmless. Now CRISPR can tell the difference - Genetic Literacy Project

Ovarian cancer – News, Research and Analysis – The Conversation – page 1

CRISPR/Cas9 system in breast cancer therapy: advancement, limitations and future scope, Cancer Cell International

Exploring nano-enabled CRISPR-Cas-powered strategies for efficient diagnostics and treatment of infectious diseases

Scientists who claimed Crispr caused mutations now admit they CAN'T replicate their results

Ovarian cancer – News, Research and Analysis – The Conversation – page 1

IJMS, Free Full-Text

Bacterial protoplast-derived nanovesicles carrying CRISPR-Cas9 tools re-educate tumor-associated macrophages for enhanced cancer immunotherapy

Genetics LocalHealthGuide

Home – Articles, Analysis, Opinion – The Conversation – page 492

How CRISPR Is Changing Cancer Research and Treatment - NCI

A new study suggests CRISPR gene editing therapies should be customized for each patient